Guanghui Wang Selected Research

Long Noncoding RNA

6/2022	SNHG10/miR-141-3p/WTAP axis promotes osteosarcoma proliferation and migration.
5/2021	Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
12/2018	Long non-coding RNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma by targeting miR‑206.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guanghui Wang Research Topics

Disease

64	Neoplasms (Cancer) 07/2022 - 07/2006
20	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2020 - 06/2007
19	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 06/2012
13	Parkinson Disease (Parkinson's Disease) 01/2021 - 05/2007
11	Neoplasm Metastasis (Metastasis) 12/2022 - 06/2011
11	Carcinogenesis 07/2022 - 11/2010
9	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2012
9	Infections 12/2021 - 04/2005
8	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 08/2006
6	Adenocarcinoma of Lung 01/2022 - 01/2017
6	Inflammation (Inflammations) 01/2022 - 01/2013
6	Liver Neoplasms (Liver Cancer) 04/2019 - 09/2006
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2011
5	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2020 - 06/2007
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 03/2013
4	Osteosarcoma (Osteogenic Sarcoma) 06/2022 - 05/2018
4	Ischemia 10/2015 - 02/2011
3	Wounds and Injuries (Trauma) 12/2022 - 12/2012
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 11/2012
3	Neuroinflammatory Diseases 01/2022 - 08/2012
3	Glioma (Gliomas) 01/2022 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2010
3	Huntington Disease (Huntington's Disease) 01/2020 - 12/2015
3	Lung Neoplasms (Lung Cancer) 10/2019 - 01/2012
3	Frontotemporal Dementia (Semantic Dementia) 10/2019 - 05/2015
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2015
3	Nasopharyngeal Carcinoma 06/2017 - 12/2010
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2016 - 01/2015
2	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 05/2022
2	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2016
2	Movement Disorders (Movement Disorder) 01/2021 - 01/2020
2	Colitis 01/2021 - 01/2019
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2020 - 12/2015
2	Allergic Rhinitis 11/2018 - 08/2003
2	Colonic Neoplasms (Colon Cancer) 11/2017 - 01/2017
2	Necrosis 03/2017 - 12/2012
2	Multiple Myeloma 01/2017 - 03/2016
2	Tissue Adhesions 09/2016 - 01/2016
2	Fibrosis (Cirrhosis) 09/2016 - 12/2014
2	Adenocarcinoma 04/2015 - 12/2010
2	Schizophrenia (Dementia Praecox) 01/2015 - 12/2010

Drug/Important Bio-Agent (IBA)

44	Proteins (Proteins, Gene)FDA Link 07/2022 - 05/2007
15	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2009
13	Messenger RNA (mRNA)IBA 07/2022 - 12/2010
9	Pharmaceutical PreparationsIBA 01/2022 - 07/2006
9	UbiquitinIBA 01/2020 - 05/2007
8	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2016
8	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2012
8	Phosphotransferases (Kinase)IBA 05/2019 - 09/2007
7	Biological ProductsIBA 01/2022 - 01/2012
5	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 11/2009
5	CytokinesIBA 01/2016 - 08/2003
5	Ataxin-3IBA 08/2014 - 06/2007
4	polyglutamineIBA 01/2020 - 06/2007
3	Long Noncoding RNAIBA 06/2022 - 12/2018
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 05/2022 - 01/2013
3	Serine (L-Serine)FDA Link 01/2022 - 10/2018
3	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2019
3	SynucleinsIBA 01/2021 - 01/2019
3	Lysine (L-Lysine)FDA Link 01/2021 - 12/2012
3	CateninsIBA 01/2021 - 05/2013
3	RNA (Ribonucleic Acid)IBA 09/2020 - 05/2013
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2015
3	Peptide Hydrolases (Proteases)FDA Link 11/2019 - 04/2005
3	Cadherins (E-Cadherin)IBA 01/2019 - 06/2011
2	CaspasesIBA 07/2022 - 01/2014
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022 - 01/2014
2	Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA 01/2022 - 10/2018
2	Radiation-Sensitizing AgentsIBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2015
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 09/2019
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022 - 10/2018
2	Caspase 3 (Caspase-3)IBA 01/2022 - 11/2019
2	Amino Acids FDA Link 01/2021 - 04/2019
2	Orphan Nuclear ReceptorsIBA 07/2020 - 01/2016
2	Superoxide Dismutase-1IBA 01/2020 - 11/2009
2	Protein Isoforms (Isoforms)IBA 01/2020 - 04/2005
2	Hydroxymethyl and Formyl TransferasesIBA 12/2019 - 10/2018
2	Sirtuin 3IBA 12/2019 - 10/2018
2	LuciferasesIBA 09/2019 - 06/2017
2	Conditioned Culture MediaIBA 05/2019 - 12/2018
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 08/2018 - 01/2018
2	carbazoleIBA 01/2018 - 01/2017
2	Ligases (Synthetase)IBA 01/2018 - 03/2016
2	Protein AggregatesIBA 01/2018 - 12/2015
2	ResveratrolIBA 10/2017 - 03/2012
2	LipopolysaccharidesIBA 03/2017 - 12/2014
2	Ubiquitinated ProteinsIBA 01/2017 - 12/2015
2	Therapeutic UsesIBA 01/2017 - 11/2012
2	ChromatinIBA 11/2016 - 04/2011
2	Hydroxyproline (4 Hydroxyproline)IBA 09/2016 - 12/2014
2	Fibrinogen (Factor I)FDA Link 09/2016 - 01/2016
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2016 - 01/2015
2	LigandsIBA 09/2015 - 12/2012
2	Peptides (Polypeptides)IBA 01/2015 - 04/2005
2	DysbindinIBA 01/2015 - 12/2010

Therapy/Procedure

9	Therapeutics 07/2022 - 11/2011
3	Drug Therapy (Chemotherapy) 08/2022 - 10/2014
2	Segmental Mastectomy (Lumpectomy) 05/2022 - 09/2013
2	Radiotherapy 05/2022 - 01/2018